Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/16/2003WO2003084511A1 Palatable chewable tablet
10/16/2003WO2003084510A1 Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions
10/16/2003WO2003084509A1 Powder formulations suitable for inhalation
10/16/2003WO2003084508A1 Delivery of a substance to a pre-determined site
10/16/2003WO2003084507A2 Atomizable liposomes and their use for the pulmonary administration of active substances
10/16/2003WO2003084506A1 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
10/16/2003WO2003084504A2 Matrix for sustained, invariant and independent release of active compounds
10/16/2003WO2003084503A2 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003WO2003084502A1 Inhalation kit comprisung inhalable powder of tiotropium
10/16/2003WO2003084498A1 Hydrogel adhesives for use on hair or fiber-populated surfaces
10/16/2003WO2003084481A2 Biological affinity based delivery systems
10/16/2003WO2003084476A2 Treatment of lung disorder
10/16/2003WO2003084470A2 Compositions and methods for targeted biological delivery of molecular carriers
10/16/2003WO2003084467A2 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003WO2003084386A2 Methods for ultrasonic imaging and treating diseased tissues
10/16/2003WO2003084338A1 Chewing gum in powder form and a method of preparation
10/16/2003WO2003068247B1 Eye installation based on iodine anions
10/16/2003WO2003066030A3 Pharmaceutical tablet
10/16/2003WO2003066029A3 Pharmaceutical dosage form for mucosal delivery
10/16/2003WO2003061620A3 Peptide-carrying bodies for immune response
10/16/2003WO2003061545A3 Therapeutic decorative object
10/16/2003WO2003059280A3 Efficient liposomal encapsulation
10/16/2003WO2003055834A3 Method for the production of $g(a) mannite directly compressible into tablets
10/16/2003WO2003055410A3 Composition and method for treatment of otitis externa
10/16/2003WO2003047493A3 Stabilized reverse micelle compositions and uses thereof
10/16/2003WO2003046145A3 Materials and methods for making improved liposome compositions
10/16/2003WO2003045352A3 Osmotic delivery device having a two-way valve and dynamically self-adjusting flow channel
10/16/2003WO2003037314A3 Medical compositions for intravesical treatment of bladder cancer
10/16/2003WO2003037159A3 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/16/2003WO2003035790A3 Improved method for generating an aerosol
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003032957A3 Methods for hermetically sealing microchip reservoir devices
10/16/2003WO2003032922A3 Stabilized azithromycin compositions
10/16/2003WO2003026743A3 Opioid formulations having reduced potential for abuse
10/16/2003WO2003026626A3 Modified release dosage forms
10/16/2003WO2003026492A3 Prevention and treatment of restenosis by local administration of drug
10/16/2003WO2003022997A3 Human tissue urokinase type plasminogen activator formulation
10/16/2003WO2003022260B1 Use of methotrexate and l-arginine for the preparation of a medicament for treatment of uterine myoma
10/16/2003WO2003022218A3 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
10/16/2003WO2003020335A3 Dual stage microvalve and method of use
10/16/2003WO2003020241A3 Functional powders for oral delivery
10/16/2003WO2003015707A3 Method for treating lung cancers
10/16/2003WO2003011247A3 Support matrix comprising particles loaded with active ingredient for application on the skin or mucous membrane
10/16/2003WO2003007802A9 Pharmaceutical combinations of oxycodone and naloxone
10/16/2003WO2003005968A3 Dual release levodopa ethyl ester and decarboxylase inhibitor with immediate release levodopa
10/16/2003WO2003000233A3 Delivery of small hydrophilic molecules packaged into lipid vesicles
10/16/2003WO2002100382A3 Controlled release dosage forms using acrylic polymer, and process for making the same
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
10/16/2003WO2002094216A3 Delivery of stimulants through an inhalation route
10/16/2003WO2002085299A3 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/16/2003WO2002080884A3 Powder inhaler formulations
10/16/2003WO2002056865A3 Peat product composition, method for the production and use thereof
10/16/2003WO2002055101A9 Storage stable powder compositions of interleukin-4 receptor
10/16/2003WO2002055058A3 Flexible microchip devices for ophthalmic and other applications
10/16/2003WO2002034304A9 Self-adhesive hydratable matrix for topical therapeutic use
10/16/2003US20030195527 Patch stabilization of rods for treatment of cardiac muscle
10/16/2003US20030195491 Automatic liquid injection system and method
10/16/2003US20030195462 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
10/16/2003US20030195254 Immediate release and stabilized formulation
10/16/2003US20030195253 Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
10/16/2003US20030195249 Crystal structured benzenesulfonic acid salts of 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol, used as sustained release antidepressants
10/16/2003US20030195246 Seamless soft capsule preparations containing dihydrobenzofuran derivatives
10/16/2003US20030195228 Pharmaceutical compositions for hepatitis C viral protease inhibitors
10/16/2003US20030195225 Acidification of drugs such as carbendazim, by mixing with buffers improving water solubility; anticarcinogenic agents
10/16/2003US20030195220 Preparations for oral administration
10/16/2003US20030195214 Cancer treatment
10/16/2003US20030195179 Redispersibility comprising polyvinylpyrrolidone and a water-soluble anionic macromolecular compound which are added to prevent a hardly soluble drug from adhering to a container and forming aggregates
10/16/2003US20030195178 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and thereof
10/16/2003US20030195171 Method for inhibiting bone resorption with an alendronate and vitamin D formulation
10/16/2003US20030195170 Tablets for treatment of osteoporosis
10/16/2003US20030195150 Antimicrobial peptides
10/16/2003US20030195143 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteoanabolically active substance
10/16/2003US20030195140 Methods and compositions for improving sleep
10/16/2003US20030195133 For delivery of fragrances and other active ingredients onto fabric, hair, skin, and other biological surfaces and which provides prolonged release of active ingredients or yields high impact fragrance "burst" upon treatment
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194762 Use making a claimed cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods
10/16/2003US20030194456 Extract of the leaves and/or stem of Argemone mexicana plant for treatment of psoriasis and related biochemical and immunological disorders
10/16/2003US20030194452 Improved herbal composition having antiallergic properties and a process for the preparation thereof
10/16/2003US20030194445 Modified oligopeptide and a biocide, a biodispersant, a germicide, a preservative, an antibacterial agent, an antiviral agent, an antifungal agent or an antiparasitic agent.
10/16/2003US20030194444 Methods of treating skin and integument conditions
10/16/2003US20030194443 External solid phase containing a polyhydroxyalkanoate and an internal phase that is a second solid phase, a liquid phase or a gaseous phase; drugs, agricultural products, cosmetics
10/16/2003US20030194442 Insoluble drug particle compositions with improved fasted-fed effects
10/16/2003US20030194441 Antibacterial aqueous solutioncomprises: methylcellulose; citric acid; polyethylene glycol and an active drug component, especially a quinolone antibiotic; viscosity of 12 mPa.s or below at 20 degrees C.
10/16/2003US20030194440 Pharmaceutical composition for sustained release of the hmg-coa reductase inhibitor fluvastatin
10/16/2003US20030194439 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/16/2003US20030194438 Ionically bound to hyaluronic acid, poly-gamma-glutamic acid or other ionic polymers, utilizing counter-ions of different valences to control the rate of release into the body.
10/16/2003US20030194437 Levothyroxine compositions having unique triiodothyronine Cmax properties
10/16/2003US20030194436 Levothyroxine salt and a pharmaceutically acceptable carrier.
10/16/2003US20030194435 In particular dry plant extracts, wherein the acid donor of the effervescent couple is a dried fruit juice with a natural acid pH, such as freeze-dried citrus fruit juice.
10/16/2003US20030194434 Bubbling tablet, bubbling bath additive tablet, bubbling washing detergent tablet, bubbling tablet for oral administration, and process for producing these
10/16/2003US20030194431 Delivering active ingredients or medicaments having diverse physical states (e.g., solid, liquid, gas or dispersion) into a single dosage, multi-compartment capsule.
10/16/2003US20030194430 Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions
10/16/2003US20030194429 Primary and secondary capsules contain a nutraceutical, a vitamin, a dietary supplement and/or a mineral
10/16/2003US20030194428 Process for encapsulating multi-phase, multi-compartment capsules
10/16/2003US20030194422 Methods of administering levothyroxine pharmaceutical compositions
10/16/2003US20030194421 Treatment of uveitis
10/16/2003US20030194420 Non-bioadhesive backing layer, a bioadhesive layer and an active ingredient
10/16/2003US20030194418 Breakable capsule used to deliver a topical chemical treatment, particularly a pesticide, to livestock.
10/16/2003US20030194416 Fragrance encapsulated by moisture sensitive microspheres
10/16/2003US20030194415 Film-forming compositions and methods
1 ... 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 ... 2991